pre-IPO PHARMA

COMPANY OVERVIEW

Nereid Therapeutics, an ATP company, is discovering new disease treatments using proprietary state-of-the-art technologies for generating, visualizing, and measuring liquid-liquid phase separation and the resulting biomolecular condensates. Nereid applies leading expertise in soft matter physics and cell biology to pioneer completely new ways to fight intractable diseases.


LOCATION

  • Cambridge, MA, USA

  • THERAPEUTIC AREAS


    WEBSITE

    https://nereidtx.com/


    CAREER WEBSITE

    https://nereidtx.com/#join-us


    SOCIAL MEDIA


    INVESTORS

    apple-tree-partners


    PRESS RELEASES


    Nov 1, 2021

    Nereid Therapeutics Announces Scientific Advisory Board Membership


    Oct 25, 2021

    Nereid Therapeutics Announces Appointments of Laura Forese and Rupert Vessey to Its Board of Directors


    Nov 16, 2020

    Nereid Therapeutics Launches: ATP $50M Series A NewCo Co-Founded with Brangwynne, Pioneer of Biomolecular Condensates Field


    For More Press Releases


    Google Analytics Alternative